Sanofi?s Lantus Doubled Cancer Risk in Study of Diabetics

[Northerner]

Sanofi?s Lantus, the world?s top- selling insulin with $4.7 billion in annual revenue, more than doubled the risk of developing cancer among people with diabetes, researchers said.

Diabetics who used Lantus had a 2.9-fold greater chance of cancer, while those who took the generic drug metformin had an 8 percent lower risk, according to the study presented yesterday at the San Antonio Breast Cancer Symposium. Researchers examined medical records of 23,266 patients in southern Sweden.

http://www.businessweek.com/news/20...oubled-cancer-risk-in-study-of-diabetics.html

But read the full article to discover that other studies have shown no link, so a misleading headline

 

[Robster65]

I have googled about this before and found the same sort of consensus. I don't necessarily trust the manufacturer (anyone who promotes the autopen24 can't be for real 🙄) but by now there would have been bans somewhere if it was conclusive.

ANother reason to look at pumping perhaps 🙂

Rob